• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定表达膜锚定流感神经氨酸酶的荧光条形码细胞系。

Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases.

作者信息

Finney Joel, Kuraoka Masayuki, Song Shengli, Watanabe Akiko, Liang Xiaoe, Liao Dongmei, Moody M Anthony, Walter Emmanuel B, Harrison Stephen C, Kelsoe Garnett

机构信息

Laboratory of Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Department of Integrative Immunobiology, Duke University, Durham, NC 27710, USA.

出版信息

Vaccine. 2025 May 22;56:127157. doi: 10.1016/j.vaccine.2025.127157. Epub 2025 Apr 21.

DOI:10.1016/j.vaccine.2025.127157
PMID:40262372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12086040/
Abstract

The discovery of broadly protective antibodies to the influenza virus neuraminidase (NA) has raised interest in NA as a vaccine target. However, recombinant, solubilized tetrameric NA ectodomains are often challenging to express and isolate, hindering the study of anti-NA humoral responses. To address this obstacle, we established a panel of 22 non-adherent cell lines stably expressing native, historical N1, N2, N3, N9, and NB NAs anchored on the cell surface. The cell lines are barcoded with fluorescent proteins, enabling high-throughput, 16-plex analyses of antibody binding with commonly available flow cytometers. The cell lines were at least as efficient as a Luminex multiplex binding assay at identifying NA antibodies from a library of unselected clonal IgGs derived from human memory B cells. The cell lines were also useful for measuring the magnitude and breadth of the serum antibody response elicited by experimental infection of rhesus macaques with influenza virus. The membrane-anchored NAs are catalytically active and are compatible with established sialidase activity assays. NA-expressing K530 cell lines therefore represent a useful tool for studying NA immunity and evaluating influenza vaccine efficacy.

摘要

对流感病毒神经氨酸酶(NA)具有广泛保护作用的抗体的发现,引发了人们对将NA作为疫苗靶点的兴趣。然而,重组、可溶解的四聚体NA胞外结构域的表达和分离往往具有挑战性,这阻碍了对抗NA体液免疫反应的研究。为了解决这一障碍,我们建立了一组22个非贴壁细胞系,它们能稳定表达锚定在细胞表面的天然、具有历史代表性的N1、N2、N3、N9和NB型NA。这些细胞系用荧光蛋白进行了条形码标记,可使用常用的流式细胞仪对抗体结合进行高通量、16重分析。在从源自人类记忆B细胞的未选择克隆IgG文库中鉴定NA抗体方面,这些细胞系至少与Luminex多重结合测定法一样有效。这些细胞系还可用于测量恒河猴经流感病毒实验感染后引发的血清抗体反应的强度和广度。膜锚定的NA具有催化活性,并且与已建立的唾液酸酶活性测定法兼容。因此,表达NA的K530细胞系是研究NA免疫和评估流感疫苗效力的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/c00d04bcb2c4/nihms-2077071-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/ebb9890e9205/nihms-2077071-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/bf829ee2bfd6/nihms-2077071-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/9b59609946c2/nihms-2077071-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/2f7e5d3ea46f/nihms-2077071-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/c00d04bcb2c4/nihms-2077071-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/ebb9890e9205/nihms-2077071-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/bf829ee2bfd6/nihms-2077071-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/9b59609946c2/nihms-2077071-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/2f7e5d3ea46f/nihms-2077071-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d227/12086040/c00d04bcb2c4/nihms-2077071-f0005.jpg

相似文献

1
Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases.稳定表达膜锚定流感神经氨酸酶的荧光条形码细胞系。
Vaccine. 2025 May 22;56:127157. doi: 10.1016/j.vaccine.2025.127157. Epub 2025 Apr 21.
2
Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases.稳定表达膜锚定流感神经氨酸酶的荧光条形码细胞系。
bioRxiv. 2025 Jan 2:2025.01.01.631020. doi: 10.1101/2025.01.01.631020.
3
Binding antibody titers against the hemagglutinin and neuraminidase correlate with protection against medically attended influenza A and B disease.针对血凝素和神经氨酸酶的结合抗体滴度与预防甲型和乙型流感就医疾病的保护作用相关。
J Virol. 2025 Jun 17;99(6):e0039125. doi: 10.1128/jvi.00391-25. Epub 2025 May 13.
4
Evaluation of an N1 NA antibody-specific enzyme-linked lectin assay for detection of H5N1 highly pathogenic avian influenza virus infection in vaccinated birds.用于检测接种疫苗禽类中H5N1高致病性禽流感病毒感染的N1 NA抗体特异性酶联凝集试验的评估
J Virol Methods. 2025 May;334:115127. doi: 10.1016/j.jviromet.2025.115127. Epub 2025 Feb 15.
5
The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.2009 年至 2017 年期间人类流感 N2 神经氨酸酶的抗原景观。
Elife. 2024 May 28;12:RP90782. doi: 10.7554/eLife.90782.
6
Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.嵌合 M2e-H3 茎蛋白或多亚型神经氨酸酶加 M2e 病毒样颗粒疫苗对雪貂流感病毒的交叉保护作用。
Virology. 2024 Jul;595:110097. doi: 10.1016/j.virol.2024.110097. Epub 2024 Apr 25.
7
Vaccines for preventing influenza in healthy children.用于预防健康儿童流感的疫苗。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004879. doi: 10.1002/14651858.CD004879.pub5.
8
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.用于预防和治疗健康成人及儿童流感的神经氨酸酶抑制剂。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3.
9
An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virus.一种流感mRNA疫苗可保护雪貂免受高致病性甲型禽流感病毒A(H5N1)的致命感染。
Sci Transl Med. 2024 Dec 18;16(778):eads1273. doi: 10.1126/scitranslmed.ads1273.
10
Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.用佐剂重组神经氨酸酶进行疫苗接种可诱导对小鼠流感病毒感染产生广泛的异源交叉保护,但不是异亚型交叉保护。
mBio. 2015 Mar 10;6(2):e02556. doi: 10.1128/mBio.02556-14.

本文引用的文献

1
Probable extinction of influenza B/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases.流感 B/Yamagata 株可能灭绝及其对公共卫生的影响:系统文献回顾和全球监测数据库评估。
Lancet Microbe. 2024 Aug;5(8):100851. doi: 10.1016/S2666-5247(24)00066-1. Epub 2024 May 7.
2
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase.保护性人源单克隆抗体针对流感病毒神经氨酸酶底面的保守弱点部位。
Immunity. 2024 Mar 12;57(3):574-586.e7. doi: 10.1016/j.immuni.2024.02.003. Epub 2024 Mar 1.
3
The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.
B/山形流感病毒传播的终结——从四价疫苗过渡
N Engl J Med. 2024 Apr 11;390(14):1256-1258. doi: 10.1056/NEJMp2314801. Epub 2024 Feb 28.
4
Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin.针对流感血凝素前融合和融合后表位的保护性人抗体。
Proc Natl Acad Sci U S A. 2024 Jan 2;121(1):e2316964120. doi: 10.1073/pnas.2316964120. Epub 2023 Dec 26.
5
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.利用疫苗诱导的保护性抗体来确定流感 N2 神经氨酸酶上的保守表位。
Immunity. 2023 Nov 14;56(11):2621-2634.e6. doi: 10.1016/j.immuni.2023.10.005.
6
A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.通过模拟受体抑制神经氨酸酶的泛流感抗体。
Nature. 2023 Jun;618(7965):590-597. doi: 10.1038/s41586-023-06136-y. Epub 2023 May 31.
7
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.一种针对所有已知流感病毒亚型的多价核苷修饰 mRNA 疫苗。
Science. 2022 Nov 25;378(6622):899-904. doi: 10.1126/science.abm0271. Epub 2022 Nov 24.
8
A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases.一种广泛保护性的人源单克隆抗体,针对甲型和乙型流感病毒神经氨酸酶的唾液酸酶活性。
Nat Commun. 2022 Nov 3;13(1):6602. doi: 10.1038/s41467-022-34521-0.
9
Infant Antibody Repertoires during the First Two Years of Influenza Vaccination.婴儿在接种流感疫苗后的头两年中的抗体库。
mBio. 2022 Dec 20;13(6):e0254622. doi: 10.1128/mbio.02546-22. Epub 2022 Oct 31.
10
A cell-based multiplex immunoassay platform using fluorescent protein-barcoded reporter cell lines.一种使用荧光蛋白条形码报告细胞系的基于细胞的多重免疫分析平台。
Commun Biol. 2021 Nov 25;4(1):1338. doi: 10.1038/s42003-021-02881-w.